ZB002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZB002, covering 2025-04-08 to 2025-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis [Phase 1]